Simplex Trading’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-47,280
Closed -$655K – 10454
2026
Q2
$1.16M Buy
47,280
+44,958
+1,936% +$812K ﹤0.01% 2622
2026
Q1
$40.6K Sell
2,322
-538
-19% -$10.4K ﹤0.01% 6091
2025
Q4
$37.8K Buy
2,860
+1,455
+104% +$12.9K ﹤0.01% 5905
2025
Q3
$8K Sell
1,405
-13,876
-91% -$65K ﹤0.01% 8068
2025
Q2
$63K Sell
15,281
-6,322
-29% -$25.5K ﹤0.01% 5702
2025
Q1
$81K Buy
+21,603
New +$100K ﹤0.01% 5288

Other funds holding BIOA

Simplex Trading's BIOA Position: Q3 2026 in Review

Simplex Trading sold out of BioAge Labs (BIOA) in Q3 2026, closing a stake of 47,280 shares — an estimated $655K sold.

Simplex Trading first reported a position in BIOA in Q1 2025 and held it in 6 quarters. The position peaked at $1.16M in Q2 2026. 161 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

  • Simplex Trading reported no remaining BioAge Labs position as of Q3 2026 after selling out during the quarter.
  • Simplex Trading sold 47,280 BioAge Labs shares in Q3 2026, an estimated $655K.
  • Simplex Trading first reported a position in BioAge Labs in Q1 2025 and held it in 6 quarters.
  • Simplex Trading's BioAge Labs position peaked at $1.16M in Q2 2026.
  • 161 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.